Implementation of the ERAS in Colorectal Cancer Patients: a Single Arm Study
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: ERAS protocol.
- Who it may be relevant to
- Registry conditions: Colorectal Cancer. Basic parameters: from 19 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- South Korea
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Implementation of the Early Recovery After Surgery (ERAS) Protocol in Colorectal Cancer Patients: a Phase II Multi-Center, Prospective Single Arm Study
Overview
The goal of this study is to implement and investigate the efficacy of an Early Recovery After Surgery (ERAS) protocol in South Korean colorectal cancer patients. The primary outcome will be the postoperative time taken to achieve the 'discharge criteria'. Secondary outcomes will include adherence, hospital stay, early complications, mortality, pain scores, re-admission and quality of life questionnaire scores. As a single arm study, all participants will be treated according to an ERAS protocol, which includes components such as early ambulation, minimal fasting, multimodal pain control and omission of- or early removal of invasive catheters.
Detailed description
This multi-center prospective single arm clinical trial aims to investigate each component and item in the ERAS protocol implemented to perioperative care of colorectal cancer patients.
The primary endpoint will be the 'postoperative time to discharge criteria'. Discharge criteria will be defined as meeting all the criteria below:
* No fever * Eating more than half of given solid diet * No nausea or vomiting * Gas passing or defecation * Able to walk (more than 1 hour a day) * No sign of surgical site infection * Adequate pain control with oral analgesics such as acetaminophen and NSAIDs * No sign of any other complication
Secondary outcomes will include:
* adherence of each ERAS item within the protocol * postoperative hospital stay * early postoperative complications (within 30 days of surgery) * postoperative mortality * postoperative pain scores (VAS scores) * re-admission within 30 days of surgery * Quality of Recovery questionnaire * Health-related quality of life questionnaire
The specific ERAS protocol to be used in this study has been developed by Seoul National University Hospital, benchmarking the 2018 ERAS® society guidelines for colorectal surgery. The implementation process has been helped and guided by the ERAS® Implementation Program of the Encare team.
The ERAS protocol includes:
* Pre-admission education, counselling and nutritional support * Pre-induction oral analgesics * Minimal fasting and carbohydrate loading * Omission of nasogastric intubation * Intra-operative abdominal nerve block * Early mobilization * Early oral nutrition and minimal IV fluids * Multimodal opioid sparing analgesia * Postoperative nausea and vomiting prophylaxis * Early removal of urinary catheters
This study aims to establish evidence on the factors affecting adherence and efficacy of each ERAS category, to guide a future pivotal RCT that will aim to develop a personalized, risk-stratified ERAS protocol that considers surgical risk and patient factors.
Interventions
- Procedure ERAS protocol
The ERAS protocol includes: * Pre-admission education, counselling and nutritional support * Pre-induction oral analgesics * Minimal fasting and carbohydrate loading * Omission of nasogastric intubation * Intra-operative abdominal nerve block * Early mobilization * Early oral nutrition and minimal IV fluids * Multimodal opioid sparing analgesia * Postoperative nausea and vomiting prophylaxis * Early removal of urinary catheters
Primary outcome measures
- Postoperative time to discharge criteria [Time frame: From the date of surgery until the date of first achieving all of the discharge criteria, assessed up to 100 days]
Secondary outcome measures (7)
- Adherence to the ERAS protocol [Time frame: From date of enrollment to the date of discharge after surgery, assessed up to 100 days]
- Hospital stay [Time frame: From the date of hospital admission until the date of discharge after surgery, assessed up to 100 days]
- Early postoperative complication [Time frame: From the day of surgery to the 30th postoperative day]
- Postoperative mortality [Time frame: From day of surgery until the end of clinical data gathering, assessed upto 100 days.]
- Postoperative pain score: the Numeric Rating Scale (NRS) [Time frame: From day of surgery until the end of clinical data gathering, assessed upto 100 days.]
- Re-admission within 30 days [Time frame: From randomization until the end of clinical data gathering, assessed upto 100 days.]
- Health-related Quality of Life [Time frame: From randomization until the end of clinical data gathering, assessed upto 100 days.]
Eligibility criteria
Inclusion criteria
- Above the age of 19 years
- Pathologic diagnosis of colon cancer or rectal cancer
- Scheduled for minimally invasive (laparoscopic or robotic) colorectal cancer surgery
- Agreed to participate after a detailed explanation of the study
Exclusion criteria
- Stage 4 (distant metastasis)
- Emergency surgery
- Scheduled for transanal surgery
- Perforated colorectal cancer
- Obstructed colorectal cancer
- Familial colorectal cancer (HNPCC, FAP, MUYH polyposis, Peutz-Jeghers syndrome)
- Previous treatment for colorectal cancer
- History of other cancer within 5 years (excluding skin cancer)
- Acute infection
- Unable to read or understand the study
- Mental impairment
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
South Korea · 1 center
- Seoul National University Hospital — Seoul
Identifiers
NCT: NCT06729736 · 2410-124-1579